Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Andreotti

Showing results (11-20 of 368) with videos related to

Pageof 37
Sort By:
Clinical and Experimental Immunology|January 24, 2004
Interleukin-15 production by monocyte-derived dendritic cells and T cell proliferation in HIV-infected patients with discordant response to highly active antiretroviral therapyG d'Ettorre, G Forcina, M Andreotti, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 12, 2013
HIV-1 coreceptor switch during 2 years of structured treatment interruptionsS Baroncelli, C M Galluzzo, M Andreotti, et al.
Thescientificworldjournal|December 31, 2014
Phantom eye syndrome: a review of the literatureAgda M Andreotti, Marcelo C Goiato, Eduardo P Pellizzer, et al.
Gerodontology|April 24, 2012
Effect of thermal cycling and disinfection on colour stability of denture base acrylic resinMarcelo C Goiato, Daniela M Dos Santos, Gabriella T Baptista, et al.
Reumatismo|April 20, 2021
Children with Kawasaki disease or Kawasaki-like syndrome (MIS-C/PIMS) at the time of COVID-19: are they all the same? Case series and literature reviewA Marino, T Varisco, G Quattrocchi, et al.
HIV Medicine|May 23, 2009
The mutational archive in proviral DNA does not change during 24 months of continuous or intermittent highly active antiretroviral therapyLucia Palmisano, M Giuliano, C M Galluzzo, et al.
HIV Medicine|January 21, 2004
Risk factors and occurrence of rash in HIV-positive patients not receiving nonnucleoside reverse transcriptase inhibitor: data from a randomized study evaluating use of protease inhibitors in nucleoside-experienced patients with very low CD4 levels (<50 cells/microL)M Floridia, R Bucciardini, V Fragola, et al.
Haematologica|October 17, 2001
High dose of idarubicin-based regimen for diffuse large cell AIDS-related non-Hodgkin's lymphoma patients: a pilot studyR Gastaldi, P Martino, G Gentile, et al.
Journal of Chemotherapy (Florence, Italy)|April 13, 2011
Adherence and genotypic drug resistance mutations in HIV-1-infected patients failing current antiretroviral therapyG d'Ettorre, G Forcina, G Ceccarelli, et al.
AIDS (London, England)|March 15, 2000
Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volumeA Vigano, S Vella, M Saresella, et al.
Pageof 37

Showing results (11-20 of 368) with videos related to

Sort By:
Pageof 37
Clinical and Experimental Immunology|January 24, 2004
Interleukin-15 production by monocyte-derived dendritic cells and T cell proliferation in HIV-infected patients with discordant response to highly active antiretroviral therapyG d'Ettorre, G Forcina, M Andreotti, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 12, 2013
HIV-1 coreceptor switch during 2 years of structured treatment interruptionsS Baroncelli, C M Galluzzo, M Andreotti, et al.
Thescientificworldjournal|December 31, 2014
Phantom eye syndrome: a review of the literatureAgda M Andreotti, Marcelo C Goiato, Eduardo P Pellizzer, et al.
Gerodontology|April 24, 2012
Effect of thermal cycling and disinfection on colour stability of denture base acrylic resinMarcelo C Goiato, Daniela M Dos Santos, Gabriella T Baptista, et al.
Reumatismo|April 20, 2021
Children with Kawasaki disease or Kawasaki-like syndrome (MIS-C/PIMS) at the time of COVID-19: are they all the same? Case series and literature reviewA Marino, T Varisco, G Quattrocchi, et al.
HIV Medicine|May 23, 2009
The mutational archive in proviral DNA does not change during 24 months of continuous or intermittent highly active antiretroviral therapyLucia Palmisano, M Giuliano, C M Galluzzo, et al.
HIV Medicine|January 21, 2004
Risk factors and occurrence of rash in HIV-positive patients not receiving nonnucleoside reverse transcriptase inhibitor: data from a randomized study evaluating use of protease inhibitors in nucleoside-experienced patients with very low CD4 levels (<50 cells/microL)M Floridia, R Bucciardini, V Fragola, et al.
Haematologica|October 17, 2001
High dose of idarubicin-based regimen for diffuse large cell AIDS-related non-Hodgkin's lymphoma patients: a pilot studyR Gastaldi, P Martino, G Gentile, et al.
Journal of Chemotherapy (Florence, Italy)|April 13, 2011
Adherence and genotypic drug resistance mutations in HIV-1-infected patients failing current antiretroviral therapyG d'Ettorre, G Forcina, G Ceccarelli, et al.
AIDS (London, England)|March 15, 2000
Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volumeA Vigano, S Vella, M Saresella, et al.
Pageof 37